Replimune

Business Services · Massachusetts, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

500 Unicorn Park Dr Fl 3, Woburn, Massac...

Phone Number

(781) 222-9600

Revenue

-

Stock Symbol

REPL

Industry

Business Services Manufacturing Research & Development Chemicals & Related Products

About Replimune

Replimune Group, based in Massachusetts, is a company specializing in cancer therapy and developing immunotherapies that focus on improving anti-tumor effects of the chosen, patient specific immunotherapy as well as the potency of the immune systems response. Replimune is a biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response.Explore more
Replimune's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: REPLShow more

Replimune Org Chart

PhoneEmail
KX
United States flag for contact location.

Chief Medical Officer

PhoneEmail
SG
United States flag for contact location.

Senior VP & General Counsel

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JH
United States flag for contact location.

Vice President & Head of Medical Writing

PhoneEmail
AY
United States flag for contact location.

Global Vice President, Medical Affairs

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Replimune

Compare insights from companies similar to Replimune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Replimune

201-500
Public
$526M
2015
KX
Konstantinos XynosChief Medical Officer
$1.1B
501-1,000
Private
$721.1M
2008
DA
David AchesonExecutive Vice President, Head of Global Commercial
$330.5M
201-500
Public
$293.9M
1996
$325M
501-1,000
Public
$1.1B
2007
Frederick G. Vogt, Interim Chief Executive Officer & General Counsel at Iovance Biotherapeutics
Frederick G. VogtInterim CEO & General Counsel
$316.5M
201-500
Public
$40M
2012
Tatjana Mitchell, Chief Financial Officer, At Evolus (Nasdaq Eols) at Evolus
Tatjana MitchellChief Financial Officer, At Evolus (Nasdaq Eols)
$145.5M
201-500
Private
<$5M
2002
Kenneth Bilenberg, Group President & Chief Executive Officer at Avid Bioservices
Kenneth BilenbergGroup President & CEO
<$5M
201-500
Public
$472.1M
2015
Illustration of an envelope

Replimune Tech Stack

A closer look at the technologies used by Replimune

Top Business Services Companies

Frequently Asked Questions Regarding Replimune

What is Replimune's stock symbol?
Replimune's stock symbol is REPL
What is Replimune's official website?
Replimune's official website is www.replimune.com
What is Replimune's SIC code?
Replimune's SIC: 28,283
What is Replimune's NAICS code?
Replimune's NAICS: 32,325
How many employees does Replimune have?
Replimune has 201-500 employees
What industry does Replimune belong to?
Replimune is in the industry of: Business Services, Manufacturing, Research & Development
What is Replimune competition?
Replimune top competitors include: Iovance Biotherapeutics, Dynavax Technologies, Apellis Pharmaceuticals, Avid Bioservices
What technology does Replimune use?
Some of the popular technologies that Replimune uses are: WordPress.org, reCAPTCHA, iCIMS, PHP
How do I contact Replimune?
Replimune contact info: Phone number: (781) 222-9600 Website: www.replimune.com
What does Replimune do?

Replimune Group, based in Massachusetts, is a company specializing in cancer therapy and developing immunotherapies that focus on improving anti-tumor effects of the chosen, patient specific immunotherapy as well as the potency of the immune systems response. Replimune is a biotech company focused on revolutionizing cancer treatment with a new clas... s of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response.Read More

What are Replimune social media links?
Replimune Linkedin page Replimune Twitter page
Who invested in Replimune?
Replimune has 15 investors including Atlas Venture, Omega Funds, Forbion and Atlas Ventures.
Is Replimune a public company?
Yes, Replimune is a public company and is traded under the symbol REPL
See more information about Replimune

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.